Fundraising Fox

Felice Verduyn - Van Weegen

Investor

Partner at EQT Life Sciences

Amsterdam, Netherlands

Writes $11M – $65M checks Β· typically $25M

FoundedEvommune

Experience

  1. EQT GroupPartnercurrent2022 β€” presentAmsterdam, North Holland, Netherlands
  2. Agomab TherapeuticsMember Board of Directorscurrent2023 β€” presentGent, Vlaanderen, BelgiΓ«
  3. EvommuneMember Board Of Directorscurrent2021 β€” presentVerenigde Staten
  4. Noema PharmaMember Board of Directorscurrent2024 β€” present
  5. Vico TherapeuticsMember of the Supervisory Boardcurrent2019 β€” presentLeiden, Provincie Zuid-Holland, Nederland
  6. Egle TherapeuticsMember Board Of Directorscurrent2021 β€” present
  7. LSPPartnercurrent2021 β€” present
  8. LSPInvestment Manager2015 β€” 2021Amsterdam Area
  9. EQT FoundationChairman of Grant Committeecurrent2025 β€” present
  10. De ZorgambassadeChairman of the supervisory board2019 β€” 2026
  11. Amolyt PharmaMember Board Of Directors2019 β€” 2024Lyon Area, France
  12. Pharvaris B.V.Board Observer2016 β€” 2021
  13. ONWARDBoard Observer2015 β€” 2018
  14. McKinsey & CompanyFellow2012 β€” 2014
  15. Harvard Medical SchoolGenetic research fellow2011Boston
  16. Vrije Universiteit AmsterdamGenetic and Twin Research2009 β€” 2011
  17. Dutch Twin Registry - Vrije UniversiteitGenetic and Twin Research2010

Education

  1. Columbia Business SchoolMaster of Business Administration (MBA)2014 β€” 2015
  2. Vrije Universiteit Amsterdam (VU Amsterdam)MsC, Neurosciences2005 β€” 2011
  3. Erasmus University RotterdamMsC, Neurosciences2010
  4. Vrije Universiteit Amsterdam (VU Amsterdam)Bachelor's degree, Biological Psychology2005 β€” 2008

Skills & more

Dutch3Strategy8Management4Statistics7Research6Neuroscience3SPSS3Business Strategy9Management Consulting8Data Analysis2Due Diligence3Valuation4
+3 moreMergers & AcquisitionsCorporate FinanceEntrepreneurship

From Felice's professional profile.

Same school

Shared employers

Deals Β· 1

EvommuneBoard seat

via EQT Life Sciences Β· filed Jan 2025 Β· $115.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at EQT Life Sciences

Network5

Investors connected to Felice in public investor directories β€” a warm-intro map.